
CASE DISCUSSION
Diabetes and Nerve Damage: Understanding Diabetic Peripheral Neuropathy
Presented from by Dr. Sumon Chowdhary
0
Credit Points
0
Learning Hours
0
CPD/CME Points
0
Courses Completed
Case Description
Diabetic peripheral neuropathy is one of the most common and debilitating complications of long-standing diabetes, significantly impacting patients’ quality of life. This webinar will delve into the mechanisms behind nerve damage, early warning signs, and the clinical tools required for accurate...
Case Summary
- Diabetic peripheral neuropathy (DPN) results from nerve fiber damage in the peripheral nervous system due to diabetes, specifically affecting somatic nerves. The most common type is chronic insidious sensory neuropathy, characterized by progressive pain, hypersensitivity, muscle wasting, and autonomic dysfunction in the legs and feet. Other types include acute painful neuropathy (sudden, unilateral pain), diffuse motor neuropathy (generalized muscle wasting and weakness), and focal neuropathy (pressure or vascular damage to specific nerves).
Speaker Profile

Dr. Sumon Chowdhary
Endocrinologist, Chittagong Diabetic General Hospital, BangladeshDr. Sumon Chowdhury is a Consultant in Endocrinology at Chittagong Diabetic General Hospital in Bangladesh. He specializes in the diagnosis and management of hormonal and metabolic disorders, including diabetes, thyroid diseases, and other endocrine conditions. With a strong commitment to patient-centered care, he focuses on providing evidence-based treatment and long-term disease management. Dr. Chowdhury is also actively involved in promoting diabetes awareness and improving endocrinology services within the community.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.